Merck joins the list of drug makers agreeing to freeze or lower some prices
“It’s as clear as the drug pricing system is clear,” Dr. Walid Gellad said about vows to halt price hikes.
As political pressure on the pharmaceutical industry builds, Merck has become the latest big drug maker to commit to halting price hikes.
In a brief , the company agreed not to increase the average net prices of its medicines by more than inflation annually, and then also dropped the wholesale — or list — price by 60 percent on its Zepatier hepatitis C treatment and lowered list prices by 10 percent
